WAT

Waters
D

WAT

Arincen65/100B

Waters financials

Yes. Waters earned 98.21M USD of net income over the last twelve months, 1.8% of its revenue. It made a profit in 29 of its 31 fiscal years since 1995. Its last loss was in fiscal year 1997.

Revenue (TTM)
5.61B USD
Net income (TTM)
98.21M USD
Free cash flow (TTM)
291.58M USD
Cash and short-term investments
593.00M USD
Total debt
5.13B USD
Shareholders' equity
15.29B USD

Cash, debt and equity as of 3 Oct 2026.

Waters earnings

Next earnings · Q4 FY2026
EPS estimate
4.63 USD
Revenue estimate
1.81B USD
Last quarter · Q3 FY2026
EPS4.10Beat +2.5%Revenue1.77BBeat +0.8%

Revenue

ReportedEstimate

EPS

ReportedEstimate
PeriodReport dateEPS estimateReported EPSSurpriseEPS growthRevenue estimateReported revenueSurpriseRevenue growth
Q3 FY20274.51——+9.89%1.84B——+4.37%
Q2 FY20273.62——+18.66%1.74B——+6.07%
Q1 FY20273.20——+18.64%1.61B——+27.08%
Q4 FY20264.63——+2.21%1.81B——+94.36%
Q3 FY20264.004.10+2.50%+20.59%1.75B1.77B+0.75%+120.91%
Q2 FY20263.013.05+1.33%+3.39%1.62B1.65B+1.40%+113.27%
Q1 FY20262.312.70+16.88%+20.00%1.20B1.27B+5.30%+91.48%
Q4 FY20254.514.53+0.44%+10.49%928.34M932.36M+0.43%+6.83%
Q3 FY20253.213.40+5.92%+16.04%781.01M799.89M+2.42%+8.05%
Q2 FY20252.942.95+0.34%+12.17%748.66M771.33M+3.03%+8.86%

Waters growth and profitability

Full income statement
Revenue (TTM)
5.61B USD
Net income (TTM)
98.21M USD
Gross margin
49.44%
Operating margin
4.73%
Net margin
1.75%

Revenue / Net income

Revenue Net income Net margin
PeriodRevenueGrowthNet incomeGrowthGross marginOperating marginNet marginEBITDAGrowth
FY20253.17B+6.99%642.63M+0.75%57.77%25.36%20.30%1.01B-2.36%
FY20242.96B+0.07%637.83M-0.69%59.43%27.93%21.56%1.04B+3.53%
FY20232.96B-0.52%642.23M-9.26%59.57%27.66%21.72%1.00B-1.58%
FY20222.97B+6.68%707.76M+2.15%58.00%29.39%23.81%1.02B+3.49%
FY20212.79B+17.78%692.84M+32.84%58.49%29.50%24.87%982.81M+25.14%

How Waters makes its money

Waters Instrument Systems1.10B 34.8%
Waters Service1.08B 34.1%
Chemistry Consumables631.46M 19.9%
Ta Instrument Systems243.82M 7.7%
Ta Service108.02M 3.4%
Revenue3.17B 100.0%
Cost of revenue1.34B 42.2%
Gross profit1.83B 57.8%
Research and development195.18M 6.2%
Selling and administration740.27M 23.4%
Other operating expenses90.64M 2.9%
Operating income802.59M 25.4%
Tax112.25M 3.5%
Other expense47.71M 1.5%
Net income642.63M 20.3%

FY2025, in USD. Each band is as wide as its money; the percentage is its share of revenue.

Waters revenue breakdown

By product

FY2025
Waters Instrument Systems: 34.8%Waters Service: 34.1%Chemistry Consumables: 19.9%Ta Instrument Systems: 7.7%Ta Service: 3.4%34.8%Waters Instrument Systems34.1%Waters Service19.9%Chemistry Consumables7.7%Ta Instrument Systems3.4%Ta Service
SegmentRevenueShare of revenueChange on the year
Waters Instrument Systems1.10B34.8%+6.7%
Waters Service1.08B34.1%+7.3%
Chemistry Consumables631.46M19.9%+11.7%
Ta Instrument Systems243.82M7.7%-1.0%
Ta Service108.02M3.4%+0.2%

By region

FY2025
Americas: 36.7%Asia Pacific: 32.9%Europe: 30.4%36.7%Americas32.9%Asia Pacific30.4%Europe
RegionRevenueShare of revenueChange on the year
Americas1.16B36.7%+4.1%
Asia Pacific1.04B32.9%+7.3%
Europe963.38M30.4%+10.3%

Operating and free cash flow

Full cash flow statement
Operating cash flow Free cash flow
Fiscal yearOperating cash flowFree cash flow
FY2025652.56M539.81M
FY2024762.12M619.64M
FY2023602.81M442.18M
FY2022611.66M428.21M
FY2021747.27M579.01M
FY2020790.51M618.12M
FY2019643.09M479.26M
FY2018604.45M476.88M
FY2017697.64M607.17M
FY2016629.08M534.11M

Waters financial health

Full balance sheet
Cash and short-term investments
593.00M USD
Total debt
5.13B USD
Net cash
-4.54B USD
Free cash flow (TTM)
291.58M USD
Current ratio
1.55
Debt to equity
0.34
Piotroski score
5 / 9
Altman Z-score
4.10

Cash, debt and free cash flow

Cash and short-term investments Total debt Free cash flow
Fiscal yearCash and short-term investmentsTotal debtFree cash flow
FY2025587.83M1.49B539.81M
FY2024325.36M1.70B619.64M
FY2023395.97M2.44B442.18M
FY2022481.39M1.66B428.21M
FY2021569.29M1.60B579.01M

Assets, liabilities and equity

Total assets Total liabilities Shareholders' equity
Fiscal yearTotal assetsTotal liabilitiesShareholders' equity
FY20255.08B2.52B2.56B
FY20244.55B2.73B1.83B
FY20234.63B3.48B1.15B
FY20223.28B2.78B504.49M
FY20213.09B2.73B367.55M
FY20202.84B2.61B232.14M
FY20192.56B2.77B-216.28M
FY20183.73B2.16B1.57B
FY20175.34B3.11B2.23B
FY20164.66B2.36B2.30B

Waters valuation

Price to earnings ratio (TTM)
195.29
Forward P/E (FY2026)
31.27
Price to sales (TTM)
8.03
Price to book
2.95
EV / EBITDA (TTM)
43.96

Capital structure

Market capitalization
45.06B USD
+
Total debt
5.13B USD
−
Cash and short-term investments
593.00M USD
=
Enterprise value
49.60B USD

Valuation over time

P/EForward P/EForward P/E · EstimateEstimate
Fiscal yearP/EForward P/EP/SP/BEV/EBITDA
FY2028 (est.)24.69————
FY2027 (est.)27.7724.69———
FY2026 (est.)31.2727.77———
Now (TTM)195.2928.198.032.9543.96
FY202535.1728.287.148.8323.23
FY202434.5128.287.4412.0422.57
FY202330.2927.916.5816.9121.48
FY202229.0329.306.9140.7321.37
FY202133.1231.268.2462.4224.46

Waters against its own history

Each figure in the latest fiscal year against the same figure from FY2021 to FY2025: the range, its median (the line) and the latest (the dot, green on the good side of the median). The P/E is today's against its daily readings of five years.

Its peers: IQVIA Holdings, Agilent Technologies, Natera, IDEXX Laboratories, Mettler-Toledo International, and Illumina, the US Medical - Diagnostics & Research companies closest to it in size, each in its own latest fiscal year: their median (the line) and its rank among them, first being the best.

  • P/E (today)Above its median195.3
    20.8202.4
  • Gross marginLowest in 5 years57.8%
    57.8%59.6%
    Against its peers: 5 of 7Peers' median 60.6%
  • Operating marginLowest in 5 years25.4%
    25.4%29.5%
    Against its peers: 3 of 7Peers' median 20.6%
  • Net marginLowest in 5 years20.3%
    20.3%24.9%
    Against its peers: 3 of 7Peers' median 19.2%
  • Return on equityLowest in 5 years25.1%
    25.1%188.5%
    Against its peers: 3 of 6Peers' median 20.9%
  • Free cash flow marginAt its median17.1%
    14.4%20.9%
    Against its peers: 4 of 7Peers' median 18.8%
  • Revenue growthAbove its median7.0%
    -0.5%17.8%
    Against its peers: 3 of 7Peers' median 6.3%
  • EPS growthAt its median0.5%
    -7.6%33.6%
    Against its peers: 5 of 5Peers' median 4.3%
  • Debt to EBITDALowest in 5 years1.47×
    1.47×2.44×
    Against its peers: 2 of 6Peers' median 1.83×
  • Current ratioLowest in 5 years1.73
    1.732.39
    Against its peers: 4 of 7Peers' median 1.56

Peers: US companies of the same industry (of its sector when the industry has too few) from a tenth to ten times its market value, the six closest in size. Updated weekly.

Waters dividends

Frequency
Irregular
Last payment
0.16 USD
Last ex-dividend date
26 Nov 1996

Dividends per share

Year1996
Dividends per share0.04

Waters ownership

Institutions
120.28%
Institutional holders
1,203 (+9)
Free float
99.88%

Who owns the shares

Institutions 100.0% Others 0.0%
As of 30 Jun 2026

Shares free to trade

Free float 98.07M shares ·99.9% Closely held 120.49K shares ·0.1%

Closely held shares belong to insiders, founders and owners of more than 5%, and seldom change hands. The free float is the rest: the shares anyone can buy and sell.

Insider trading

QuarterPurchasesSalesShares acquiredShares disposed of
Q3 2026013.74K7.25K
Q2 202600130.45730.00
Q1 20262075.17K4.89K
Q4 2025003.88K5.08K

Shares outstanding

Basic shares Diluted shares Change in diluted shares
Fiscal yearBasic sharesDiluted sharesChange in diluted shares
FY202559.51M59.71M+0.26%
FY202459.33M59.55M+0.48%
FY202359.08M59.27M-1.76%
FY202259.99M60.33M-2.74%
FY202161.58M62.03M-0.62%

Common questions about Waters's financials

Source: Financial Modeling PrepVerified against SEC filings